In order to obtain this action we must pay 0,47$ right now, Celyad SA is a company created in Belgium dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in Europe. Its Executives are Charles Q. Morris (Chief Medical Officer), David Gilham (Chief Scientific Officer), Filippo Joseph Petti (Director, Chief Executive & Financial Officer), Frederic Lehmann (VP-Clinical Development & Medical Affairs), Peggy Sotiropoulou (Head-Research & Development), Stephen Rubino (Chief Business Officer) and its address is RUE EDOUARD BELIN 2 AXIS BUSINESS PARK, MONT-SAINT-GUIBERT, 1435, Belgium.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 0,50$ moving between 0,47$ and 0,53$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
